How a global biopharma became a leader in ethical AI
EY teams used the global Responsible AI framework to help a biopharma optimize AI governance, mitigate AI risks and protect stakeholders.
A detailed independent review of AI governance
EY teams collaborated with the biopharma to review its approach to AI ethics using the global Responsible AI framework.
Driving responsible AI to reduce risk to stakeholders
EY teams helped the biopharma safeguard stakeholders, including the public, from AI ethical issues.
On the agenda (8)Skip
Diversity, equity and inclusiveness
Strategy by EY-Parthenon
People and workforce
An open letter from Carmine di Sibio, EY Global Chairman and CEO
A message of support and reassurance to our people, clients and communities.